CN108601952B - 雷公藤内酯的葡萄糖缀合物、类似物及其用途 - Google Patents
雷公藤内酯的葡萄糖缀合物、类似物及其用途 Download PDFInfo
- Publication number
- CN108601952B CN108601952B CN201780010159.3A CN201780010159A CN108601952B CN 108601952 B CN108601952 B CN 108601952B CN 201780010159 A CN201780010159 A CN 201780010159A CN 108601952 B CN108601952 B CN 108601952B
- Authority
- CN
- China
- Prior art keywords
- cancer
- syndrome
- disease
- autoimmune
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (21)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662291416P | 2016-02-04 | 2016-02-04 | |
US62/291,416 | 2016-02-04 | ||
PCT/US2017/016527 WO2017136739A1 (en) | 2016-02-04 | 2017-02-03 | Glucose conjugates of triptolide, analogs and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108601952A CN108601952A (zh) | 2018-09-28 |
CN108601952B true CN108601952B (zh) | 2022-03-04 |
Family
ID=59500284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780010159.3A Active CN108601952B (zh) | 2016-02-04 | 2017-02-03 | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 |
Country Status (8)
Country | Link |
---|---|
US (2) | US10695319B2 (zh) |
EP (1) | EP3411121A4 (zh) |
JP (1) | JP7042744B2 (zh) |
CN (1) | CN108601952B (zh) |
AU (1) | AU2017214572A1 (zh) |
CA (1) | CA3013619A1 (zh) |
MX (1) | MX2018009406A (zh) |
WO (1) | WO2017136739A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109942665B (zh) * | 2018-04-02 | 2021-04-06 | 欣凯医药化工中间体(上海)有限公司 | 雷公藤内酯醇衍生物及其制备方法和应用 |
CN109897053B (zh) * | 2019-03-28 | 2020-05-29 | 中国医学科学院医药生物技术研究所 | 雷斯吲哚甲及其制备方法和抗丙型肝炎病毒用途 |
CN111040018A (zh) * | 2019-12-30 | 2020-04-21 | 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) | 丙烯酸雷公藤甲素酯、其制备方法及其应用 |
WO2021134272A1 (zh) | 2019-12-30 | 2021-07-08 | 广东省中医院 | 丙烯酸雷公藤甲素酯、其制备方法及其应用 |
EP4114468A1 (en) * | 2020-03-02 | 2023-01-11 | The Johns Hopkins University | Glucose triptolide conjugates and uses thereof |
EP4200022A1 (en) | 2020-08-21 | 2023-06-28 | Reyoung Corporation | Triptolide conjugates and uses thereof |
CN115286684A (zh) * | 2022-05-20 | 2022-11-04 | 福建医科大学 | 一种糖与雷公藤内酯醇或其衍生物的缀合物及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020099051A1 (en) * | 2001-01-19 | 2002-07-25 | Fidler John M. | Anticancer treatment using triptolide prodrugs |
US6569893B2 (en) * | 2001-03-15 | 2003-05-27 | Pharmagenesis, Inc. | Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents |
US20140107077A1 (en) * | 2009-05-07 | 2014-04-17 | Regents Of The University Of Minnesota | Triptolide prodrugs |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6218367B1 (en) * | 1998-09-15 | 2001-04-17 | Organomed Corporation | Paclitaxel-carbohydrate conjugates: design, synthesis and biological evaluations |
-
2017
- 2017-02-03 CN CN201780010159.3A patent/CN108601952B/zh active Active
- 2017-02-03 US US16/074,750 patent/US10695319B2/en active Active
- 2017-02-03 CA CA3013619A patent/CA3013619A1/en not_active Abandoned
- 2017-02-03 EP EP17748283.3A patent/EP3411121A4/en active Pending
- 2017-02-03 AU AU2017214572A patent/AU2017214572A1/en not_active Abandoned
- 2017-02-03 WO PCT/US2017/016527 patent/WO2017136739A1/en active Application Filing
- 2017-02-03 MX MX2018009406A patent/MX2018009406A/es unknown
- 2017-02-03 JP JP2018540128A patent/JP7042744B2/ja active Active
-
2020
- 2020-06-11 US US16/899,226 patent/US20200297693A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020099051A1 (en) * | 2001-01-19 | 2002-07-25 | Fidler John M. | Anticancer treatment using triptolide prodrugs |
US6569893B2 (en) * | 2001-03-15 | 2003-05-27 | Pharmagenesis, Inc. | Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents |
US20140107077A1 (en) * | 2009-05-07 | 2014-04-17 | Regents Of The University Of Minnesota | Triptolide prodrugs |
Non-Patent Citations (5)
Title |
---|
(14S)-14-O-beta-D-Glucopyranosyltriptolide;——;《DATABASE PUBCHEM》;20151218;1 * |
——.(14S)-14-O-beta-D-Glucopyranosyltriptolide.《DATABASE PUBCHEM》.2015,1. * |
Chemo-enzymatic Synthesis of Propionyl-ester-linked Taxol-monosaccharide Conjugate and its Drug Delivery System Using Hybrid-Bio-nanocapsules Targeting Brain Glioma Cells;Hiroki Hamada et al.;《Clinical Medicine Insights:Women’s Health》;20131231;第6卷;71-75 * |
Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties;Pengxing Liu et al.;《CHEMICAL COMMUNICATIONS》;20130201;第49卷;2421-2423 * |
Synthesis of 2’-paclitaxel methyl 2-glucopyranosyl succinate for specific targeted delivery to cancer cells;Der-Zen Liu et al.;《Bioorganic & Medicinal Chemistry Letters》;20061107;第17卷;617-620 * |
Also Published As
Publication number | Publication date |
---|---|
AU2017214572A1 (en) | 2018-08-16 |
CN108601952A (zh) | 2018-09-28 |
MX2018009406A (es) | 2018-11-09 |
US20200297693A1 (en) | 2020-09-24 |
US10695319B2 (en) | 2020-06-30 |
EP3411121A1 (en) | 2018-12-12 |
WO2017136739A1 (en) | 2017-08-10 |
CA3013619A1 (en) | 2017-08-10 |
JP7042744B2 (ja) | 2022-03-28 |
EP3411121A4 (en) | 2019-12-18 |
US20190038596A1 (en) | 2019-02-07 |
JP2019509986A (ja) | 2019-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108601952B (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
KR102396307B1 (ko) | 전립선 암의 내부방사선요법을 위한 전립선-특이적 막 항원 표적화된 고-친화성 제제 | |
HRP20201446T1 (hr) | Konjugati analoga cc-1065 i bifunkcionalnih veznika | |
ES2918425T3 (es) | Conjugados de anticuerpo-fármaco | |
JP2019529444A5 (zh) | ||
JP2016505586A5 (zh) | ||
JP7103953B2 (ja) | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート | |
ES2576497T3 (es) | Compuesto de piperidina novedoso o sal del mismo | |
JP2019504100A5 (zh) | ||
JP2016506916A5 (zh) | ||
RS20080002A (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
ES2909486T3 (es) | Sistemas de administración para liberación controlada de fármaco | |
WO2017201132A2 (en) | Pyrrolobenzodiazepines and conjugates thereof | |
JP2009530424A5 (zh) | ||
WO2007064345A3 (en) | Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use | |
JP2012528240A5 (zh) | ||
JP2018507844A (ja) | 抗体薬物コンジュゲート | |
ES2702911T3 (es) | Agente antitumoral que incluye una baja dosis de clorhidrato de irinotecán hidratado | |
JP2019509986A5 (zh) | ||
JPWO2015034032A1 (ja) | 抗腫瘍剤及び抗腫瘍効果増強剤 | |
JP2014524449A5 (zh) | ||
ES2685974T3 (es) | Derivados de cefalosporina para tratar el cáncer | |
ES2824400T3 (es) | Agente antitumoral que incluye clorhidrato de irinotecán hidratado | |
JP2007515399A5 (zh) | ||
JP6580030B2 (ja) | カンプトテシン誘導体とhsp90阻害剤の結合した高分子化合物及びその用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: J.Liu Inventor after: He Qingli Inventor after: M.G. Pomper Inventor after: Min Yi Inventor after: Yu Biao Inventor after: Wang Qiaoling Inventor before: J.Liu Inventor before: He Qingli Inventor before: M.G. Pomper Inventor before: Ai Miln Inventor before: Yu Biao Inventor before: Wang Qiaoling |
|
GR01 | Patent grant | ||
GR01 | Patent grant |